Your session is about to expire
← Back to Search
Understanding Episodic Memory in Epilepsy
N/A
Waitlist Available
Led By Ueli Rutishauser, PhD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥13
Intractable epilepsy, undergoing invasive monitoring
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Summary
This trial involves monitoring brain cell activity and using small electrical pulses to understand how memories are formed and used. It targets patients with drug-resistant epilepsy because their treatment allows direct study of brain activity. By observing and stimulating brain cells, researchers aim to learn more about memory and decision-making.
Who is the study for?
This trial is for individuals aged 13 or older with intractable epilepsy who are already undergoing invasive monitoring. Participants should have an IQ over 70 and be able to understand and perform tasks on a computer by pressing buttons. Those unable to complete the tasks due to cognitive, psychological limits, or pain cannot join.
What is being tested?
The study aims to understand how humans learn, recall information, and make decisions using various devices: Cedrus response pad for inputs; Adtech micro-electrodes, Neurolynx system for brain activity recording; Blackrock stimulator possibly for stimulating specific brain areas during tests.
What are the potential side effects?
Since this trial involves non-drug interventions focused on monitoring and testing brain function rather than treatment side effects may include discomfort from wearing the equipment or potential risks associated with invasive monitoring as determined by clinicians.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 13 years old or older.
Select...
I have severe epilepsy and am undergoing special monitoring.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Decision Making (Firing Rates)
Decision Making (Power)
Decision Making (Timing)
+4 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Behavioral TestingExperimental Treatment1 Intervention
Behavioral and Neuronal Recordings
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Epilepsy treatments aim to modulate neuronal activity to prevent seizures. Transcranial Magnetic Stimulation (TMS) uses magnetic fields to stimulate nerve cells in the brain, potentially reducing seizure frequency by altering cortical excitability.
This noninvasive method is particularly useful for patients who do not respond well to medication. Other common treatments include antiepileptic drugs (AEDs) that stabilize neuronal membranes and reduce excitability, and surgical interventions that remove or isolate the seizure focus.
Understanding these mechanisms is crucial for epilepsy patients as it helps tailor treatment plans to individual needs, improving outcomes and quality of life.
Find a Location
Who is running the clinical trial?
California Institute of TechnologyOTHER
15 Previous Clinical Trials
3,049 Total Patients Enrolled
1 Trials studying Epilepsy
50 Patients Enrolled for Epilepsy
Cedars-Sinai Medical CenterLead Sponsor
509 Previous Clinical Trials
165,713 Total Patients Enrolled
1 Trials studying Epilepsy
50 Patients Enrolled for Epilepsy
Johns Hopkins UniversityOTHER
2,315 Previous Clinical Trials
14,872,523 Total Patients Enrolled
19 Trials studying Epilepsy
1,289 Patients Enrolled for Epilepsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable to perform certain tasks due to cognitive, psychological issues, or pain.I am 13 years old or older.You have an IQ score higher than 70.I have severe epilepsy and am undergoing special monitoring.I can understand and respond to simple tasks on a computer.
Research Study Groups:
This trial has the following groups:- Group 1: Behavioral Testing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger